|
🐜
|
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
23 auth.
J. Korn,
M. Mayes,
M. Cerinic,
M. Rainisio,
J. Pope,
E. Hachulla,
É. Rich,
P. Carpentier,
J. Molitor,
J. Seibold,
...
V. Hsu,
L. Guillevin,
Sharmila Chatterjee,
H. Peter,
J. Coppock,
A. Herrick,
P. Merkel,
R. Simms,
C. Denton,
D. Furst,
N. Nguyen,
M. Gaitonde,
C. Black
|
9 |
2004 |
9
🐜
|
|
🐬
|
The Sales Lead Black Hole: On Sales Reps' Follow-Up of Marketing Leads
Gaurav Sabnis,
Sharmila Chatterjee,
Rajdeep Grewal,
G. Lilien
|
6 |
2013 |
6
🐬
|
|
🐢
|
Risk indicators for recurrent aphthous ulcers among adults in the US.
A. Chattopadhyay,
Sharmila Chatterjee
|
6 |
2007 |
6
🐢
|
|
🦁
|
Prevalence of chronic illness in pregnancy, access to care, and health care costs: implications for interconception care.
Sharmila Chatterjee,
M. Kotelchuck,
U. Sambamoorthi
|
5 |
2008 |
5
🦁
|
|
🦁
|
HPV and Cervical Cancer Epidemiology - Current Status of HPV Vaccination in India.
Sharmila Chatterjee,
A. Chattopadhyay,
L. Samanta,
P. Panigrahi
|
5 |
2016 |
5
🦁
|
|
🦁
|
ARE TRUSTED BRANDS IMPORTANT
Sharmila Chatterjee
|
5 |
2005 |
5
🦁
|
|
🐜
|
Channel design, coordination, and performance: Future research directions
9 auth.
Alberto Sa Vinhas,
Sharmila Chatterjee,
S. Dutta,
Adam Fein,
J. Lajos,
S. Neslin,
...
L. Scheer,
William T. Ross,
Qiong Wang
|
5 |
2009 |
5
🐜
|
|
🐬
|
Manufacturers’ reliance on channel intermediaries: Value drivers in the presence of a direct web channel
Chia-Fen Chung,
Sharmila Chatterjee,
Sanjit Sengupta
|
5 |
2012 |
5
🐬
|
|
🐢
|
B2B relationship calculus: quantifying resource effects in service-dominant logic
Anthony J. deLeon,
Sharmila Chatterjee
|
5 |
2015 |
5
🐢
|
|
🦁
|
Cancer Registration in India - Current Scenario and Future Perspectives.
8 auth.
Sharmila Chatterjee,
A. Chattopadhyay,
S. Senapati,
D. Samanta,
Leslie Elliott,
D. Loomis,
...
L. Mery,
P. Panigrahi
|
5 |
2016 |
5
🦁
|
